Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.71 USD
Change Today +0.005 / 0.71%
Volume 39.0K
IMSC On Other Exchanges
Symbol
Exchange
OTC US
As of 1:57 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Todd A. Silvestri

Vice President of Technology & Product Development, Implant Sciences Corp.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

48$289,663
As of Fiscal Year 2014

Background*

Mr. Todd A. Silvestri serves as Vice President of Technology & Product Development at Implant Sciences Corp. Mr. Silvestri served as a Vice President of Advanced Technology and Product Development at Implant Sciences Corp. and also served as its Vice President of Product Development. Mr. Silvestri joined the Implant Sciences in September 2008 and is directly responsible for the design and commercialization of its advanced explosivetrace detection solutions. Mr. Silvestri ...

Read Full Background

Corporate Headquarters*

500 Research Drive
Wilmington, Massachusetts 01887

United States

Phone: 978-752-1700
Fax: 978-752-1711

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Clarkson University
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Salary$200,000
Total Annual Compensation$200,000

Stock Options*

All Other Compensation$265
Exercisable Options730,949
Unexercisable Options50,000
Total Number of Options780,949

Total Compensation*

Total Annual Cash Compensation$200,265
Total Short Term Compensation$200,000
Other Long Term Compensation$265
Total Calculated Compensation$289,663
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMSC:US $0.71 USD +0.005

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
$1.3M
Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
$1.1M
Frank H. Laukien Ph.D.Chairman, Chief Executive Officer and President
Bruker Corporation
$598.7K
Philippe Petitcolin Chief Executive Officer, Chairman of Morpho, Chairman of Sagem and Chief Executive Officer of Morpho
Safran SA
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPLANT SCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.